ISSN: 2173-5727

Medicina Intensiva is the journal of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICIUC), and has become the reference publication in Spanish in its field. Medicina Intensiva mainly publishes Original Articles, Reviews, Clinical Notes, Images in Intensive Medicine, and Information relevant to the specialty. All works go through a rigorous selection process.

Indexed in:

Index Medicus / MEDLINE / EMBASE / Excerpta Medica / SCOPUS / MEDES / Science Citation Index Expanded, Journal of Citation Reports

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

2.6

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.364

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.687

View more metrics

Open Access option

Journal Information

Special content about coronavirus SARS-CoV-2 (COVID-19) in Medicina Intensiva (English Edition)

Methadone as a rescue drug for difficult-to-sedate critically ill patients suffering from ARDS related to SARS-CoV-2 infection

R. Fernández-Tobar, C. Chamorro-Jambrina, M. Pérez-Torres, B. Castiñeiras-Amor, S. Alcántara-Carmona, M.A. Romera-Ortega

10.1016/j.medine.2022.02.016

Med Intensiva. 2022;46:279-81

Open Article

Impact of the COVID-19 pandemic on admissions for respiratory infections in the Pediatric Intensive Care Unit

L. Bermúdez Barrezueta, M. Brezmes Raposo, I. Sanz Fernández, P. López Casillas, C. Villa Francisco, A. Pino Vázquez

10.1016/j.medine.2022.02.015

Med Intensiva. 2022;46:281-5

Open Article

Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease

A. González-Castro, E. Cuenca Fito, A. Fernandez, P. Escudero Acha, J.C. Rodríguez Borregán, Y. Peñasco

10.1016/j.medine.2022.02.013

Med Intensiva. 2022;46:285-7

Open Article

Dexametasona en COVID-19: ¿un medicamento para todos?

A. Zangrillo, G. Landoni, G. Monti, A.G. Yavorovskiy, M. Baiardo Redaelli

10.1016/j.medine.2021.03.003

Med Intensiva. 2022;46:291-2

Open Article

Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study

Á. Estella, J.L. Garcia Garmendia, C. de la Fuente, J.F. Machado Casas, M.E. Yuste, R. Amaya Villar, M.A. Estecha, L. Yaguez Mateos, M.L. Cantón Bulnes, A. Loza, J. Mora, L. Fernández Ruiz, B. Díez del Corral Fernández, M. Rojas Amezcua, M.I. Rodriguez Higueras, I. Díaz Torres, M. Recuerda Núñez, M. Zaheri Beryanaki, F. Rivera Espinar, D.F. Matallana Zapata, S.G. Moreno Cano, B. Gimenez Beltrán, N. Muñoz, A. Sainz de Baranda Piñero, P. Bustelo Bueno, E. Moreno Barriga, J.J. Rios Toro, M. Pérez Ruiz, C. Gómez González, A. Breval Flores, A. de San José Bermejo Gómez, M.A. Ruiz Cabello Jimenez, M. Guerrero Marín, A. Ortega Ordiales, J. Tejero-Aranguren, C. Rodriguez Mejías, J. Gomez de Oña, C. de la Hoz, D. Ocaña Fernández, S. Ibañez Cuadros, J. Garnacho Montero

10.1016/j.medine.2021.02.008

Med Intensiva. 2022;46:179-91

Open Article

Health care-associated infections in patients with COVID-19 pneumonia in COVID critical care areas

J. Marin-Corral, S. Pascual-Guardia, R. Muñoz-Bermúdez, A. Salazar-Degracia, C. Climent, C. Vilà-Vilardell, M. Acer, M. Picornell, M.I. Restrepo, J.R. Masclans, F. Álvarez-Lerma

10.1016/j.medine.2021.04.013

Med Intensiva. 2022;46:221-3

Open Article